SCHEMBL24933357

SCHEMBL24933357

CCCCNC(=O)COc1ccc(-c2cc(C(N)=O)c(=O)[nH]c2C(F)(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.43
RECQL P46063 1/20 0.43
ADORA2B P29275 6/20 0.41
ADORA2A P29274 4/20 0.41
ALDH1A1 P00352 4/20 0.40
ADORA3 P0DMS8 3/20 0.40
ADORA1 P30542 3/20 0.40
MAPT P10636 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX15 P16050 1/20 0.40
PMP22 Q01453 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
BLM P54132 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933007 0.82 PPARD (0.44) ADORA2BADORA2ASMN1; SMN2
SCHEMBL24933253 0.80 HSD17B2 (0.37) ALDH1A1MAPTBLMGPR55
SCHEMBL24933256 0.80 PDK2 (0.43)
SCHEMBL24932956 0.79 FYN (0.45) ALDH1A1MAPTBLMGPR55
SCHEMBL24933847 0.78 CHEK1 (0.46)
SCHEMBL24932951 0.78 CHEK1 (0.48) ALDH1A1KDM4ESMN1; SMN2
SCHEMBL24933053 0.78 KDM4E (0.44) ALDH1A1MAPTKDM4EALOX15SMN1; SMN2
SCHEMBL24933416 0.77 HSD17B1 (0.36)
SCHEMBL24933418 0.76 MOGAT2 (0.41) ALDH1A1KDM4EHPGDCYP3A4PMP22
SCHEMBL30240687 0.76 HSD17B1 (0.35) ALDH1A1MAPTBLMGPR55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed